These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2586634

  • 21. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE, Bemis KG, Hendrix JC, Ward JS.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [Abstract] [Full Text] [Related]

  • 22. Synthesis and structure-activity studies of a series of 1-oxa-2,8-diazaspiro[4.5]decan-3-ones and related compounds as M1 muscarinic agonists.
    Tsukamoto S, Nagaoka H, Igarashi S, Wanibuchi F, Hidaka K, Tamura T.
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1523-9. PubMed ID: 7586076
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Protective effect of minaprine against the abnormal changes of 2-deoxyglucose uptake by rat hippocampal slices induced by hypoxia/hypoglycemia.
    Kodama K, Shibata S, Ueki S.
    Jpn J Pharmacol; 1992 Sep; 60(1):33-8. PubMed ID: 1361012
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM796 and YM954.
    Wanibuchi F, Konishi T, Harada M, Terai M, Hidaka K, Tamura T, Tsukamoto S, Usuda S.
    Eur J Pharmacol; 1990 Oct 23; 187(3):479-86. PubMed ID: 1963596
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies.
    Cortés R, Palacios JM.
    Brain Res; 1986 Jan 08; 362(2):227-38. PubMed ID: 3942874
    [Abstract] [Full Text] [Related]

  • 31. Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects.
    Bymaster FP, Carter PA, Peters SC, Zhang W, Ward JS, Mitch CH, Calligaro DO, Whitesitt CA, DeLapp N, Shannon HE, Rimvall K, Jeppesen L, Sheardown MJ, Fink-Jensen A, Sauerberg P.
    Brain Res; 1998 Jun 08; 795(1-2):179-90. PubMed ID: 9622623
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists.
    Ringdahl B, Roch M, Jenden DJ.
    J Pharmacol Exp Ther; 1987 Aug 08; 242(2):464-71. PubMed ID: 3612545
    [Abstract] [Full Text] [Related]

  • 35. Comparison of in vitro actions with behavioral effects of antimuscarinic agents.
    Witkin JM, Gordon RK, Chiang PK.
    J Pharmacol Exp Ther; 1987 Sep 08; 242(3):796-803. PubMed ID: 3498817
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Muscarinic cholinergic receptor subtype on frog esophageal peptic cells: binding and secretion studies.
    Dickinson KE, Matsumoto H, Anderson W, Pruitt RE, Uemura N, Hirschowitz BI.
    J Pharmacol Exp Ther; 1988 Sep 08; 246(3):879-86. PubMed ID: 2901489
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Minaprine facilitates acquisition and retrieval of an active avoidance response in the rat.
    Lorenzini CA, Baldi E, Bucherelli C, Tassoni G.
    Pharmacol Biochem Behav; 1993 Jun 08; 45(2):481-5. PubMed ID: 8327555
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.